Kim-Marie A. Dam
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS drug development and treatment 2
- Virology top 5%
- HIV Research and Treatment 6
- Animal Science and Zoology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Immune Cell Function and Interaction 2
-
- RNA and protein synthesis mechanisms 2
- vaccines and immunoinformatics approaches 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Pamela J. BjörkmanKathryn E. Huey‐TubmanHarry B. GristickClaudia A. JetteMorgan E. AbernathyShannon R. EssweinMichel C. NussenzweigChristopher O. Barnes
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Kim-Marie A. Dam
10 papers receiving 995 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Infectious Diseases 844
- Virology 98
- Animal Science and Zoology 121
- Radiology, Nuclear Medicine and Imaging 225
- Immunology 155
Countries citing papers authored by Kim-Marie A. Dam
This map shows the geographic impact of Kim-Marie A. Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim-Marie A. Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim-Marie A. Dam more than expected).
Fields of papers citing papers by Kim-Marie A. Dam
This network shows the impact of papers produced by Kim-Marie A. Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim-Marie A. Dam. The network helps show where Kim-Marie A. Dam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kim-Marie A. Dam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2023 | 23 | |
| 3 | 2022 | 15 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 44 | |
| 8 | 2021 | 9 | |
| 9 | SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesbreakdown → | 2020 | 832 |
| 10 | 2018 | 52 | |
| 11 | 2016 | 0 |
About Kim-Marie A. Dam
Kim-Marie A. Dam is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune Cell Function and Interaction (2 papers), RNA and protein synthesis mechanisms (2 papers), HIV/AIDS drug development and treatment (2 papers), vaccines and immunoinformatics approaches (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Infectious Diseases (844 citations), Virology (98 citations) and Animal Science and Zoology (121 citations). Kim-Marie A. Dam has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Pamela J. Björkman, Kathryn E. Huey‐Tubman, Harry B. Gristick, Claudia A. Jette, Morgan E. Abernathy, Shannon R. Esswein, Michel C. Nussenzweig, Christopher O. Barnes, Naima G. Sharaf and Yu E. Lee. Their work appears in journals such as Nature Communications, Nature, Scientific Reports, Journal of Macromolecular Science Part A and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.